Ian R. Creese
#116,917
Most Influential Person Now
Ian R. Creese's AcademicInfluence.com Rankings
Ian R. Creesebiology Degrees
Biology
#6828
World Rank
#9630
Historical Rank
Neuroscience
#838
World Rank
#873
Historical Rank
Download Badge
Biology
Why Is Ian R. Creese Influential?
(Suggest an Edit or Addition)Ian R. Creese's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs (1976) (1822)
- Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. (1977) (907)
- Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. (1977) (719)
- The pharmacological and anatomical substrates of the amphetamine response in the rat (1975) (582)
- Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. (1976) (459)
- Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. (1986) (451)
- Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. (1976) (410)
- Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum (1978) (394)
- 3H-Spiroperidol labels dopamine receptors in pituitary and brain. (1977) (388)
- The classification of dopamine receptors: relationship to radioligand binding. (1983) (384)
- Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. (1975) (384)
- Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. (1973) (356)
- Receptor adaptations to centrally acting drugs. (1981) (299)
- The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat (1987) (280)
- Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. (1982) (272)
- Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding. (1979) (239)
- A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood (1977) (232)
- Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake (1995) (213)
- Dopamine receptor binding in the corpus striatum of mammalian brain. (1975) (199)
- 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. (1978) (195)
- Receptor binding and pharmacological activity of opiates in the guinea-pig intestine. (1975) (183)
- Opiate receptor binding affected differentially by opiates and opioid peptides. (1979) (172)
- Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: Behavioral correlates (1993) (161)
- The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. (1975) (160)
- Functional Roles of Dopamine D2 and D3Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense KnockdownIn Vivo (1997) (147)
- Dopamine receptor subtype imbalance in schizophrenia. (1987) (142)
- Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. (1983) (139)
- Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. (1986) (133)
- Guanine nucleotides distinguish between two dopamine receptors (1979) (131)
- Ontogenesis of dopamine receptor binding in the corpus striatum of the rat (1977) (129)
- Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390. (1985) (129)
- The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat (2004) (129)
- Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides. (1978) (120)
- Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency (1976) (119)
- Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. (1984) (117)
- Amphetamine response in rat after dopamine neurone destruction. (1972) (116)
- Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum. (1986) (115)
- The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists. (1976) (115)
- Dopamine receptor binding regulated by guanine nucleotides. (1979) (111)
- Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment (1997) (111)
- Dopamine receptor turnover rates in rat striatum are age-dependent. (1984) (105)
- Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain. (1976) (100)
- 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. (1982) (99)
- Neurotransmitter receptor binding: regional distribution in human brain (1977) (99)
- Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors (1988) (97)
- Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level (1990) (96)
- Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. (1982) (95)
- Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms (1987) (94)
- Butyrophenone influences on the opiate receptor. (1976) (93)
- Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics (1996) (91)
- Species variation in dopamine receptor binding. (1979) (91)
- Biochemical Actions of Neuroleptic Drugs: Focus on the Dopamine Receptor (1978) (90)
- Dopamine receptors explained (1982) (87)
- Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors. (1983) (86)
- Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. (1997) (85)
- Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides. (1978) (82)
- Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification. (1983) (75)
- Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states. (1985) (73)
- Dopamine receptors and average clinical doses. (1976) (67)
- 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors. (1979) (66)
- Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. (1983) (66)
- Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro. (1987) (64)
- Systemic 3-nitropropionic acid: long-term effects on locomotor behavior (1994) (61)
- Dopamine receptors re-explained (1983) (60)
- Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment. (1989) (58)
- Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol. (1989) (58)
- Dopamine receptors in the central nervous system. (1982) (58)
- Discrimination by temperature of opiate agonist and antagonist receptor binding. (1975) (55)
- [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity. (1985) (55)
- Ascorbic acid enables reversible dopamine receptor 3H-agonist binding. (1981) (54)
- Kainate lesion dissociates striatal dopamine receptor radioligand binding sites. (1981) (52)
- Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): Evidence for spare receptors (1986) (51)
- D2dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum (1985) (50)
- Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584. (1974) (49)
- Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. (1992) (49)
- Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation. (1988) (48)
- Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations (1979) (47)
- Dopamine receptor binding in bovine intermediate lobe pituitary membranes. (1980) (46)
- Solubilization of D-2 dopamine receptors from canine caudate: agonist-occupation stabilizes guanine nucleotide sensitive receptor complexes. (1982) (46)
- Behavioral correlates of dopaminergic supersensitivity. (1975) (46)
- Neurobiology of Central D1-Dopamine Receptors (1986) (45)
- Agonist interactions with dopamine receptors: focus on radioligand-binding studies. (1984) (42)
- 3H-Apomorphine interactions with dopamine receptors in calf brain. (1978) (42)
- Identification of subtypes of [3H]prazosin-labelled α1 receptor binding sites in rat brain (1985) (42)
- Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment. (1987) (41)
- Antischizophrenic drugs: differential plasma protein binding and therapeutic activity. (1979) (41)
- The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol. (1975) (41)
- Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtypes in rat cerebral cortex (1986) (41)
- Chronic neuroleptic treatment and dopamine receptor regulation. (1980) (40)
- Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis (1991) (40)
- Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor. (1985) (39)
- [3H]WB4101 labels S1 serotonin receptors in rat cerebral cortex. (1984) (38)
- Intra-accumbens infusion of D3 receptor agonists reduces spontaneous and dopamine-induced locomotion (2000) (37)
- Alteration of nicotinic cholinergic agonist binding sites in hippocampus after fimbria transection (1985) (37)
- Dopamine Receptors: A Classification (1982) (37)
- 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives. (1978) (35)
- Expression of rat striatal D1 and D2 dopamine receptor mRNAs: Ontogenetic and pharmacological studies (1992) (34)
- Dopaminergic D-3 binding sites are not presynaptic autoreceptors (1983) (34)
- Dopamine receptors: subtypes, localization and regulation. (1981) (34)
- Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. (1986) (32)
- Classification of dopamine receptors. (1983) (32)
- Classical and atypical antipsychotic drugs: new insights (1983) (31)
- CNS Dopamine Receptors (1983) (31)
- Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum. (1999) (30)
- In Vitro and In Vivo Irreversible Blockade of Cortical S2 Serotonin Receptors by N‐Ethoxycarbonyl‐2‐Ethoxy‐1,2‐Dihydroquinoline: A Technique for Investigating S2 Serotonin Receptor Recovery (1986) (30)
- Radioligand binding studies: evidence for multiple dopamine receptors. (1979) (29)
- Guanine nucleotides regulate anterior pituitary dopamine receptors. (1979) (28)
- "Selective" D-1 and D-2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the rat. (1986) (25)
- Phenoxybenzamine discriminates multiple dopamine receptors. (1980) (24)
- Septal deafferentation increases hippocampal adrenergic receptors: correlation with sympathetic axon sprouting. (1983) (23)
- Reduction in muscarinic receptors by antisense oligodeoxynucleotide. (1994) (21)
- Pseudo non-competitive agonist interactions with dopamine receptors. (1980) (20)
- Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes. (1982) (19)
- MULTIPLE DOPAMINE RECEPTORS (1979) (19)
- GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum. (1997) (18)
- Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. (1989) (18)
- Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS (1984) (16)
- Dopamine receptor binding of multiple ligands (1976) (16)
- Neuroreceptors: Basic and Clinical Aspects edited by Earl Usdin, William E. Bunney, Jr and John M. Davis, John Wiley & Sons, 1981. £21.50 (xi + 279 pages) ISBN 0 471 27876 9 (1982) (15)
- Regulation of putative muscarinic cholinergic receptor subtypes in rat brain (1986) (14)
- Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia. (1986) (13)
- Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls (1981) (13)
- Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock (1982) (13)
- N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain. (1991) (13)
- Regulation of Motor Behavior by Dopamine Receptor Subtypes (1997) (12)
- Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes. (1982) (12)
- Stereospecificity and clinical potency of neuroleptics (reply) (1977) (11)
- Up-regulation of serotonergic binding sites labeled by [3H]WB4101 following fimbrial transection and 5,7-dihydroxytryptamine-induced lesions. (1985) (11)
- Radioligand Binding Studies of Agonist Interactions with Dopamine Receptors (1984) (11)
- Comments on the commentary by Dr. Seeman (1982) (10)
- Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity? (1975) (9)
- Central nervous system dopamine receptors. (1980) (9)
- Differential regulation of expression of rat hippocampal muscarinic receptor subtypes following fimbria-fornix lesion. (1997) (9)
- Dopamine receptors in the central nervous system. (1983) (8)
- Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390. (1986) (7)
- Modulation of alpha-1 adrenergic receptors in rat brain following chronic reserpine (1986) (6)
- Regulation of Agonist Interactions with Brain D-1 Dopamine Receptors (1986) (6)
- Lack of effect of chromic dopamine receptor blockade on D2 dopamine receptor mRNA levels (1990) (6)
- Receptor Biochemistry and Methodology, Volume 8: Dopamine Receptors (1989) (5)
- 6 – Dopamine Receptors (1986) (5)
- Cholinergic denervation induces adrenergic receptor increases: correlation with sympathetic axon sprouting in hippocampus. (1983) (4)
- Rate processing constraints may underlie developmental language impairments and also hemispheric specialization for speech (1999) (4)
- Multiple daily amphetamine administration decreases both [3H]agoinst and [3]antagonist dopamine receptor binding (1982) (4)
- CATECHOLAMINE RECEPTOR BINDING IN BRAIN (1979) (4)
- Identification of subtypes of [3H]prazosin-labelled alpha 1 receptor binding sites in rat brain. (1985) (4)
- Chronic effects of typical and atypical neuroleptics on glutamate receptor subtypes (1995) (4)
- Molecular actions of opiates: historical overview and new findings on opiate receptor interactions with enkephalins and guanyl nucleotides. (1979) (4)
- NEUROLEPTIC BINDING SITES IN BRAIN (1984) (4)
- Distinct localization and regulation of dopamine D3 receptors: Autoradiographic studies (1995) (3)
- Antisense knockdown of brain dopamine receptors. (1998) (3)
- Differential binding properties of some opiates and opioid peptides (1979) (3)
- Radioligand Binding Studies of Dopamine Receptors in the Central Nervous System (1983) (3)
- Dopamine receptor stimulation and striatal kainic acid neurotoxicity (1981) (3)
- Reducing Gene Expression in the Brain via Antisense Methods (1997) (3)
- Lack of Serotonergic Influence on Desipramine-Induced ß-Adrenergic Receptor Down-Regulation (1990) (3)
- Chronic Neuroleptic Treatment and Dopamine Receptor Binding: Relevance to Tardive Dyskinesia (1980) (2)
- Haloperidol, raclopride and clozapine share a common target: Medial prefrontal cortex (1995) (2)
- Chapter 4 Dopamine receptors (1997) (2)
- Discrimination of putative M1 and M2 muscarinic receptor subtypes in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (1986) (1)
- Antisense Oligodeoxynucleotide Technology (1998) (1)
- O-18-7 Antisense “Knockout” of brain dopamine receptors (1996) (1)
- Denervation-induced changes in hippocampal muscarinic receptor subtypes and their mRNAs (1993) (1)
- Dopamine D2-like receptors are elevated after chronic treatment with typical and atypical neuroleptics (1995) (1)
- Chapter 25. Brain Neurotransmitter Receptor Binding and Neuroleptic Drugs (1977) (1)
- NEW INSIGHTS INTO THE REGULATION OF DOPAMINE RECEPTOR SUBTYPES AND THEIR ROLES IN BEHAVIOR (1988) (1)
- Antisense Knockdown of Dopamine Receptors (2000) (0)
- CENTRALLY ACTING DRUGS (1981) (0)
- Dopamine Receptor Subtypes: Differential Regulatory Characteristics and Levels in Schizophrenia (1988) (0)
- United States Patent ( 19 ) Kukla ( 54 ) 1-( 10 , 11-DIHYDRO-5 H-DIBENZOAD CYCLOHEPTEN-5-YL ) METHYL-4-SUB STITUTED PIPERIDNES AND RELATED COMPOUNDS 75 Inventor : (2017) (0)
- P-11-8 Antisense “knockout” of CNS dopamine receptors (1995) (0)
- S.12.02 Antisense “knockout” of brain dopamine receptors: Potential antipsychotics? (1996) (0)
- Biochemical Characterization of Neurotransmitter Receptors in the Brain (1978) (0)
- Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390. (1986) (0)
- Book review£36.001 $83.00 Encyclopedic, The Neurobiology of Dopamine, A. S. Horn, J. Korf, B. H. C. Westerink (Eds.), Academic Press, Philadelphia, London and Toronto (1979), p. xvii + 723, ISBN: 0 12 354150 6 (1980) (0)
- Receptor binding: a tool to aid in determining the role of peptides in behavior. (1978) (0)
- £36.001 $83.00 Encyclopedic A. S. Horn (1980) (0)
- Electrophysiological Consequences of D 2 and/or D 3 Receptor Knockout by Antisense Oligonucleotides in Nigrostriatal Dopaminergic Neurons (1996) (0)
- Regulation of dopamine D2 receptors: molecular mechanisms (1991) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ian R. Creese?
Ian R. Creese is affiliated with the following schools:
